US FDA completes inspection at Alkem’s Baddi facility
The Inspection was classified as Voluntary Action Indicated (VAI)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alkem Laboratories
Building resilience to regulatory risks
Future growth of Indian pharma companies hinge on their ability to successfully navigate regulatory inspections
Alkem Laboratories brands API business as Alkem Activa
Alkem Activa plans to expand its capacity, incorporating technologies like biocatalytic and continuous manufacturing technologies
Alkem Laboratories launches awareness initiative ‘Stop Sneeze to Wheeze’
To raise awareness about coexistence of allergic rhinitis and asthma during World Allergy Week 2023
ALKEM launches asthma awareness campaign #RelieverFreeIndia
The campaign aims to spread awareness of the hazards of over-usage of reliever medications and substitute it with SMART therapy…
LPC 150 Conclave to be held at NIPER Hyderabad on March 12, 2023
The theme of the event is Pharma 4.0: Digital transformation across pharmaceuticals
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets
The funding round is led by Alkem Laboratories and new investors, Eight Roads Ventures and F-Prime Capital
Alkem becomes first Indian company to launch novel antibiotic for MDR infections
This is in line with company’s endeavour to ensure affordability, accessibility and availability while saving the lives of…
Great Place To Work India announces India’s Best Workplaces in Pharmaceuticals, Healthcare and…
This year, 15 winners have been chosen
Alkem, in partnership with Stempeutics, launches stem cell therapy to treat knee osteoarthritis
The treatment comprises a single intra-articular injection of “StemOne” in an outpatient procedure with no anaesthesia requirement